|
$538,878
|
To evaluate the impact of providing incentives for contraceptive use.
|
2018 - 2021
|
LJAF
|
|
$921,833
|
To fund the development of a centralized repository of documented medical practices that have been contradicted by rigorous, high-quality evaluations.
|
2017 - 2020
|
LJAF
|
|
$3,145,641
|
To support the Donor Management Research Initiative in its efforts to maximize the quality and quantity of life-saving organs, and to build a national, web-based donor management data registry.
|
2016 - 2022
|
LJAF
|
|
$384,252
|
To work with several state partners to evaluate and design different payment-related incentives that state health care purchasers can utilize to help reduce the use of low-value healthcare services.
|
2021 - 2022
|
LJAF
|
|
$50,729
|
To support a review of evidence for existing methadone regulatory schemes and to identify research needs to inform future methadone policy
|
2020 - 2021
|
LJAF
|
|
$597,880
|
To fund the State Medicaid Alternative Reimbursement and Purchasing Test for High-Cost Drugs Initiative.
|
2017 - 2018
|
LJAF
|
|
$2,172,049
|
To fund the State Medicaid Alternative Reimbursement and Purchasing Test for High Cost Drugs (SMART-D) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions, technical assistance, and education
|
2019 - 2022
|
LJAF
|
|
$1,582,837
|
To support efforts to improve the Medicaid drug purchasing process through research and design of value-based payment models.
|
2016 - 2017
|
LJAF
|
|
$1,735,814
|
To support the evaluation of state Medicaid policies on contraceptive access.
|
2020 - 2024
|
LJAF
|
|
$1,248,251
|
To evaluate a statewide policy in Oregon allowing pharmacists to prescribe hormonal contraception to patients without a physician visit.
|
2018 - 2022
|
LJAF
|
